This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
RETRACTION: Differential Genetic Mutations and Immune Cell Infiltration in High‐ and Low‐Risk STAD: Implications for Prognosis and Immunotherapy Efficacy
Abstract
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Lymphoma Diagnosis and Treatment · Immune Cell Function and Interaction
RETRACTION: Y.‐Y. Deng, Y. Sun, S.‐J. Wu, T.‐Y. Zhang, J. Yang and K. Liu, ‘Differential Genetic Mutations and Immune Cell Infiltration in High‐ and Low‐Risk STAD: Implications for Prognosis and Immunotherapy Efficacy’, Journal of Cellular and Molecular Medicine 28, no. 7 (2024): e18174, https://doi.org/10.1111/jcmm.18174
The above article, published online on 17 March 2024 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the Journal Editor‐in‐Chief, Stefan Constantinescu; The Foundation for Cellular and Molecular Medicine; and John Wiley and Sons Ltd. The retraction has been agreed upon as the peer review and the publishing process was found to be manipulated. No evidence of the authors' involvement in this manipulation of the publication process was found. The authors have been informed of the decision to retract but they remained unresponsive.